American Diabetes Association Issues Public Apology After Ejecting Scientists Over Trump Criticism
In a striking and widely condemned episode, the American Diabetes Association (ADA) found itself at the center of a growing controversy after forcibly removing five prominent diabetes scientists from its annual meeting. The scientists had been distributing copies of an editorial that criticized the Trump administration's impact on biomedical research. Following an intense wave of public backlash from the scientific community and beyond, the ADA's chief executive issued a formal video apology, acknowledging the organization's handling of the situation had been deeply misguided.
What Happened at the ADA Annual Meeting?
The incident occurred on a Friday during the ADA's annual scientific conference, one of the most significant gatherings in the diabetes research calendar. Five leading scientists were physically removed from the event by conference staff after they were found distributing copies of an April editorial published in Diabetes Care, the ADA's own peer-reviewed journal. The editorial in question offered a sharp and detailed critique of the Trump administration, arguing that its policies were causing significant damage and destruction to the American biomedical research enterprise.
What made the situation particularly notable was the identity of those being ejected. Among the five scientists was Steven Kahn, a professor of medicine at the University of Washington and the editor-in-chief of Diabetes Care—the very journal in which the editorial had originally been published. Also removed was Desmond Schatz, a former president of the ADA itself and a professor at the University of Florida. The fact that the association was ejecting its own former president and the editor of its flagship journal for distributing content that journal had already chosen to publish struck many observers as deeply contradictory and troubling.
The Editorial at the Center of the Controversy
The editorial that sparked the confrontation had been published in April in Diabetes Care and was co-authored by Steven Kahn along with other researchers. It addressed what the authors described as the harmful effects of the current Trump administration on the state of biomedical research in the United States. This included concerns about funding cuts, policy shifts, and institutional changes at federal health agencies that scientists argue are undermining the infrastructure of medical research that has taken decades to build.
The scientists were distributing physical copies of this editorial outside the opening session of the annual meeting—a session that had originally been scheduled to feature a keynote address by Jay Bhattacharya, the head of the National Institutes of Health (NIH) under the Trump administration. Bhattacharya canceled his appearance at the last minute, and senior NIH official Rick Woychik stepped in to deliver remarks in his place. The timing of the distribution—just outside a speech by a top Trump health official—appears to have prompted the ADA's decision to remove the scientists, a move that quickly drew fierce condemnation.
Backlash From the Scientific Community
News of the ejections spread rapidly across scientific and academic circles, triggering an immediate and powerful backlash. Researchers, physicians, and patient advocates took to social media and professional networks to express outrage at what many described as an act of censorship or political capitulation by the ADA. Critics argued that by silencing scientists for sharing peer-reviewed content from its own journal, the organization had betrayed its core mission of advancing diabetes science and advocacy.
- Prominent researchers publicly condemned the ADA's decision and called for transparency and accountability.
- Former ADA members and longtime donors questioned whether the organization was prioritizing political relationships over scientific integrity.
- Several scientific societies and advocacy groups issued statements expressing solidarity with the ejected scientists.
- Social media amplified the story rapidly, with the hashtag and discussions spreading far beyond the usual diabetes research community.
The scale and speed of the backlash appeared to catch the ADA off guard. Within days, the organization's leadership recognized it could not remain silent.
The ADA's Apology
By Wednesday—just days after the Friday ejections—the head of the American Diabetes Association posted a video publicly apologizing for the organization's actions. The apology acknowledged that the decision to remove the scientists had been wrong and expressed regret for the impact it had on those involved and on the broader scientific community's trust in the ADA. The tone of the statement reflected the severity of the backlash and the reputational damage the organization had suffered in a short period of time.
While the apology was welcomed by some, others in the scientific community noted that words alone may not be sufficient to repair the damage. Questions remain about how the decision to eject the scientists was made, who authorized it, and what safeguards the ADA will put in place to ensure scientific freedom is protected at future events.
Broader Implications for Science and Politics
This episode reflects a broader tension playing out across American scientific institutions as researchers grapple with how to respond to what many describe as an increasingly hostile environment for federally funded research. The Trump administration's approach to agencies like the NIH and the Centers for Disease Control and Prevention (CDC) has raised alarms among medical professionals about the long-term consequences for public health research.
For organizations like the ADA, which depend on both federal partnerships and the trust of the scientific community, navigating this environment is proving extraordinarily difficult. The association's misstep serves as a cautionary tale about the risks of appearing to prioritize political access over the foundational values of open scientific inquiry and free expression.
What Comes Next for the ADA and the Scientists Involved?
As of now, the five scientists have not publicly confirmed whether they accept the apology or what steps they may take in response to their removal. The ADA will likely face continued scrutiny over the coming weeks, particularly as the scientific community watches to see whether the organization follows its apology with meaningful policy changes. The incident has already sparked broader conversations about academic freedom, the politicization of health organizations, and what it means to defend science in an era of heightened institutional pressure.
For the diabetes research community and patients who depend on its work, the hope is that this moment of reckoning leads to a stronger, more transparent, and more courageous ADA going forward—one that stands firmly behind the scientists whose work ultimately saves lives.